Back to search

Article

Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinoma

2022-06-10

Abstract excerpt

<h4>Purpose: </h4> To investigate the role of NRF2 signaling in conferring superior prognosis in patients with HPV positive (HPV + ve ) head & neck squamous cell carcinomas (HNSCC) compared to HPV negative (HPV − ve ) HNSCC and develop molecular markers for selection of HPV + ve HNSCC patients for treatment de-escalation trials. Methods We compared NRF2 activity ( NRF2 , KEAP1 , and NRF2-transcriptional targets),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6cf22349-201d-5435-a098-94b0f6e76c7c
DOI
10.21203/rs.3.rs-1733748/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinomaDOI 10.21203/rs.3.rs-1733748/v1
Select a neighboring publication to make it the new centre.